OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
July 01, 2024
Following the evaluation, the company will decide whether it wants to move forward with the IDMO’s automated, end-to-end, cell therapy manufacturing platform.
The company’s latest investment—featuring new cGMP suites at its Devens, MA plant—is valued at $30 million.
The latest news for pharma industry insiders.
June 28, 2024
The North Carolina project adds 1.4 million square feet of dedicated production space for aseptic manufacturing and finished production processes.
A cross-sectional audit study determines how racial and ethnic disparities—among English, Mandarin, and Spanish-speaking patients—can impact access.
June 27, 2024
The deal offers member pharmacies two pricing options, which will take effect Aug. 1.
A longitudinal observational study examined whether the program was related to access to hospital-based services, while determining if that association differs by hospital ownership.
June 26, 2024
The agreement will look to further develop cell and gene therapies for the treatment of hematological cancers.